Expert opinion on new CF guidelines, evidence-based diagnostic modalities,
and new treatment options.
Johns Hopkins eCystic Fibrosis Review™
is the first 2008 addition to the Johns Hopkins eLiterature Review family of newsletters.
A bi-monthly CME/CE- accredited email newsletter, the program provides literature reviews and expert commentary on important cystic fibrosis topics relevant to pulmonologists, gastroenterologists, pediatricians, infectious disease specialists, respiratory therapists, dieticians, nutritionists, pharmacists, nurses, nurse practitioners, and physical therapists.
Topics for review include: Update in CF Related Diabetes (CFRD), Nutritional Challenges and Complications, Novel Inhalational Therapies, Allergic Bronchopulmonary Aspergillosis (ABPA), Vitamin D and Bone Health.
The program was launched in 2008 and has nearly 1,000 registrants after just 3 issues.
The program is accredited for physicians, nurses, and pharmacists.
eCystic Fibrosis Review is supported by educational grants from Genentech, Inc., Eurand Pharmaceuticals, Inc., Vertex Pharmaceuticals, Incorporated, Axcan Pharma, Inc. and Gilead Sciences, Inc..
